Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01783093 · ClinicalTrials.gov registry record
Tricuspid Regurgitant Jet Velocity as an Independent Marker for Mortality in Sickle Cell Anemia
A clinical trial of Pulmonary Hypertension and Sickle Cell Anemia, sponsored by Namita Sood.
- Completed
- Registry status
- 209
- Enrollment target
- 1
- Study location
NCT01783093 is a study of Pulmonary Hypertension and Sickle Cell Anemia that has completed, run by Namita Sood. The registered enrollment target is 209 participants, below the 611-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01783093, a study of Pulmonary Hypertension and Sickle Cell Anemia, has completed, sponsored by Namita Sood.
- COMPLETED
- Registry status
- 209 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate patients with pulmonary hypertension and sickle cell disease who have had multiple echocardiograms. Previous studies have shown that an elevated tricuspid jet (TR) regurgitant velocity on echo in this population is a predictor of mortality. This initial data only examined an isolated TR jet velocity. It was presumed that the mortality was related to pulmonary hypertension. It is the aim of this study to retrospectively evaluate patients who have had multiple echocardiograms and to determine if patients who had either a normalization of their TR jet velocity on a subsequent echo or had no evidence of pulmonary hypertension on right heart catheterization had a similar mortality rate to those with persistently elevated TR jet velocity.
Conditions Studied
Interventions
- OTHER Data Collection
Study Locations (1)
Ohio
- The Ohio State University Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 209 participants |
| Start Date | 2009-12 |
| Est. Completion | 2013-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01783093
The ClinicalTrials.gov registry entry for NCT01783093 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 209 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 611-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (66% lower). The listed sponsor is Namita Sood, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pulmonary Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Data Collection is the first listed.
NCT01783093 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT01783093 about?
NCT01783093 is a clinical study titled "Tricuspid Regurgitant Jet Velocity as an Independent Marker for Mortality in Sickle Cell Anemia". The purpose of this study is to evaluate patients with pulmonary hypertension and sickle cell disease who have had multiple echocardiograms. Previous studies have shown that an elevated tricuspid jet (TR) regurgitant velocity on echo in this population is a predictor of mortality. This initial data ...
What is the current status of trial NCT01783093?
This trial is currently completed. The enrollment target is 209 participants. The study started on 2009-12. Estimated completion is 2013-01.
What conditions does trial NCT01783093 study?
This clinical trial studies the following conditions: Pulmonary Hypertension, Sickle Cell Anemia.
What interventions are being tested in trial NCT01783093?
The interventions under investigation include: Data Collection (OTHER).
Who is sponsoring clinical trial NCT01783093?
This trial is sponsored by Namita Sood, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01783093 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
RECRUITING
-
Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
RECRUITING
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
RECRUITING
-
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
RECRUITING · Phase 3
-
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.